Vertex Pharmaceuticals (NQ: VRTX )
466.07
-12.50
(-2.61%)
Streaming Delayed Price
Updated: 12:21 PM EDT, Sep 5, 2024
Add to My Watchlist
Press Releases about Vertex Pharmaceuticals
![](https://mms.businesswire.com/media/20230324005339/en/1747146/5/Crispr_R-01_%281%29.jpg)
![](https://mms.businesswire.com/media/20230316005160/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20230308005894/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20230221005660/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20230207006045/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Reports Fourth Quarter and Full Year Financial 2022 Results
February 07, 2023
Via Business Wire
![](https://www.marketbeat.com/logos/articles/small_stock-image_82114730_S.jpg)
![](https://mms.businesswire.com/media/20230117005188/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20230104005247/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_413908228_S.jpg)
![](https://mms.businesswire.com/media/20221208005977/en/1660048/4/VX-522_mRNA_Infographic_FINAL_APPROVED_FOR_USE.jpg)
![](https://mms.businesswire.com/media/20221210005006/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20221207005926/en/1658806/5/EntradaLogo-Color_32.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_20038039_S.jpg)
![](https://mms.businesswire.com/media/20221109005068/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex to Participate in Upcoming Investor Conferences
November 09, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221104005186/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20221103005298/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20221027005266/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Reports Third Quarter 2022 Financial Results
October 27, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221013005726/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20221008005002/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency
October 11, 2022
Via Business Wire
![](https://www.marketbeat.com/logos/articles/small_stock-image_599560356_S.jpg)
![](https://mms.businesswire.com/media/20220927005454/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20220908005283/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Appoints Jonathan Biller as Chief Legal Officer
September 08, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220902005252/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20220831005131/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20220804005875/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Reports Second Quarter 2022 Financial Results
August 04, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220721006061/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Vertex Advances VX-548 in Acute and Neuropathic Pain
July 22, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220718005627/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20220711005280/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.